Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Prediction of PD-L1 Expression in Neuroblastoma via Computational Modeling

Immunotherapy is a promising new therapeutic approach for neuroblastoma (NBM): an anti-GD2 vaccine combined with orally administered soluble beta-glucan is undergoing a phase II clinical trial and nivolumab and ipilimumab are being tested in recurrent and refractory tumors. Unfortunately, predictive...

Full description

Bibliographic Details
Main Authors: Salvo Danilo Lombardo, Mario Presti, Katia Mangano, Maria Cristina Petralia, Maria Sofia Basile, Massimo Libra, Saverio Candido, Paolo Fagone, Emanuela Mazzon, Ferdinando Nicoletti, Alessia Bramanti
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Brain Sciences
Subjects:
neuroblastoma
PD-L1
computational modelling
immunotherapy
COPASI
Online Access:https://www.mdpi.com/2076-3425/9/9/221

Internet

https://www.mdpi.com/2076-3425/9/9/221

Similar Items